Zepbound, Wegovy, Mounjaro & Ozempic Coupons and Savings Cards (2026)

Yes, two. With commercial insurance that covers Zepbound, the Zepbound Savings Card can bring a 1- to 3-month fill down to as little as $25, but it takes off at most $100 a month and $1,300 a year. If your commercial plan does not cover it, the card brings single-dose pens to as low as $499. The separate KwikPen Self-Pay Savings Card is open to anyone, including the uninsured, and gives the self-pay price at the pharmacy: $299 for 2.5 mg, $399 for 5 mg and $449 for 7.5–15 mg. Both expire December 31, 2026.

You need commercial insurance that covers Wegovy and an eligible prescription. The Wegovy savings offer then lowers your cost to as little as $25 a month, with a maximum of $100 in savings per month. If your plan's copay is more than about $125, you'll pay more than $25. Without coverage, Novo's self-pay price is $199 a month for the first two months on the starting doses, then $349, or $149 to $299 for the Wegovy pill.

Yes. With commercial coverage you may pay as little as $25 for up to a 3-month supply, with up to $150 off per month ($450 per 3-month fill) and $1,950 per calendar year, which is a higher cap than the Zepbound, Wegovy and Ozempic cards. Without coverage the card can bring a month to as low as $499. Mounjaro is approved for type 2 diabetes, and the card can't be used with Medicare, Medicaid or other government insurance.

No. Manufacturer savings cards exclude Medicare, Medicaid, TRICARE, VA and other government plans. Medicare members have a separate option: from July 2026 through December 2027, the Medicare GLP-1 Bridge offers Wegovy (pen or pill), the Zepbound KwikPen and Foundayo for $50 a month to eligible Part D members using them for weight loss. Ozempic and Mounjaro for diabetes are covered under regular Part D rules.

GoodRx's GLP-1 offers follow the manufacturers' cash-price programs rather than adding a deeper discount. For Ozempic and Wegovy that means $199 a month introductory pricing for the starting doses, then $349. For Zepbound, the cheapest cash route is Lilly's own self-pay pricing (from $299 with the KwikPen card, through LillyDirect or participating pharmacies; Arrow Pharmacy can't process that card). A GoodRx coupon also can't be combined with insurance or a manufacturer card in the same fill.

For GLP-1s, TrumpRx lists the same cash prices the manufacturers offer: Wegovy pill $149, Wegovy pen $199 and Ozempic $199 for introductory months, and Zepbound $299. TrumpRx says these prices are only for cash-paying patients, and that insured patients should compare them with their insurance.

If your plan covers the drug and your copay is under about $125 (or $175 for Mounjaro), the savings card wins. If you have a high deductible you haven't met, your plan may charge close to the full price, and the card only takes $100–$150 off; paying the self-pay price can be cheaper, but cash payments usually don't count toward your deductible. We can price both ways before you fill.

Yes. The Zepbound and Mounjaro cards say savings end December 31, 2026, and Novo's self-pay offers carry their own end dates. Programs are renewed or changed each year, so re-check terms in December before your January fill.

By published cash price, the cheapest starting options are the Wegovy pill and Ozempic pill at $149 a month for the lowest dose, followed by Wegovy or Ozempic pens at $199 for the first two months. For maintenance doses, Wegovy and Ozempic (up to 1 mg) are $349 a month, Zepbound is $449, and the Mounjaro card's not-covered price is $499. What's cheapest for you also depends on which drug and dose your prescriber chooses.

Almost always because of the monthly cap. The Zepbound, Wegovy and Ozempic cards cover at most $100 of your cost per month (Mounjaro: $150). If your plan's copay is $300, the card covers $100 and you pay $200. Other common reasons are an unmet deductible, a prescription that doesn't match the card's approved use, or a fill beyond the yearly limit.